FDA Procurements in Brief: Funding for Continuous Manufacturing, Quality Metrics, ICH and More
This article was originally published in The Gold Sheet
FDA is funding initiatives it supports in continuous manufacturing, global regulatory harmonization, quality metrics and analysis of generic drug quality.
You may also be interested in...
Microbial and particulate contamination drove drug recalls to historic levels for a fifth year in 2014, FDA recall data shows. But the data still falters in identifying the weakest links in global pharmaceutical supply chain quality.
Boehringer expects Jardiance’s new chronic kidney disease indication to keep its sales growing by double-digit percentages over the coming years, aided by the drug’s ability to reduce hospitalizations.
With accelerated approval in advanced urothelial cancer, the sponsors now have data that could support full approval plus a move into first-line therapy.